Beam Therapeutics BEAM Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's capital investments accrued but not yet paid?
- Beam Therapeutics (BEAM) reported capital investments accrued but not yet paid of $1.39M in Q1 2026.
- How has Beam Therapeutics's capital investments accrued but not yet paid changed year-over-year?
- Beam Therapeutics's capital investments accrued but not yet paid decreased by 4.4% year-over-year, from $1.46M to $1.39M.